Patent reforms could address a problem that’s been driving rising prescription drug costs and create a more competitive ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...
Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...
Hospital volunteers at Self Regional Broaden skills and knowledge, expand your resume, and touch lives of others while ...
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...
The amount New York receives will likely depend in part on whether the state implements policies pushed by the Trump administration.
A Manitoba father who lost his son to a drug overdose is pleased to see the province is still planning to open a supervised ...
Artificial intelligence has exploded in popularity in recent years, and many proponents are excited about its potential uses in medicine: for example, processing samples quickly or identifying markers ...
The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...
Scientists have developed a simple, low-cost method to drive key chemical reactions, which could make large-scale drug ...
A bill aimed at streamlining the process of making certain prescription medicines available over the counter has been enacted ...
News-Medical.Net on MSN
Scientists urge careful evaluation before applying AI virtual staining in healthcare workflows
Artificial intelligence has exploded in popularity in recent years, and many proponents are excited about its potential uses in medicine: for example, processing samples quickly or identifying markers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results